The virologist who founded our firm closed our office ahead of the curve.
We packed up laptops and notebooks. The pessimistic among us, sensing this would not be a short hiatus, took their plants. By a window overlooking Boston, my orchid withers.
Our endeavor is to create and finance new biotechnologies. My focus—having previously led a cancer therapeutics startup—is to start new ventures based on recent scientific discoveries.
Yet for a craft so linked to biology (molecules, organs, human life), our work is remarkably distant from the physical world. We are not battlefield heroes like nurses, physicians or grocery clerks. Aside for a colleague who moonlights as an ER doc, we assume no physical risk. We don’t even go to a lab where experiments depend on our presence.